EUVIMEDEUVIMED entdecken
Open Access

Diagnostic Timing and Ovarian Cancer Survival

Sarah E Soppe, Tzy-Mey Kuo, Victoria L Bae-Jump, Benjamin B Albright, Georgios Lyratzopoulos, Chris D Baggett, Caroline A Thompson

JAMA Network Open · 27.03.2026 · 9 (3) · e262434

DOI: 10.1001/jamanetworkopen.2026.2434 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 27.03.2026. Verfasst von Sarah E Soppe und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Delayed Diagnosis, Early Detection of Cancer. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance While earlier diagnosis improves outcomes for many cancers, studies report that earlier diagnosis does not improve ovarian cancer (OC) survival, discouraging investment in diagnostic improvements. One possible explanation is confounding due to the wait time paradox, in which patients with severe disease are diagnosed more quickly but have poorer outcomes, masking potential benefits of earlier diagnosis.

Objective

To visualize how nonlinear modeling of time to diagnosis alters observed associations with OC survival, with particular attention to the wait time paradox. Design, Setting, and Participants This cohort study used data from the North Carolina Central Cancer Registry with linked multipayer claims from Medicare, Medicaid, and private insurance. Participants included female patients diagnosed with OC from January 1, 2009, to December 31, 2019, in North Carolina. Follow-up was completed June 30, 2021. Data were analyzed from May 1, 2024, to November 1, 2025. Exposure Time to diagnosis, defined as the interval from the earliest symptom-related health care encounter to cancer diagnosis. Main Outcomes and Measures All-cause 5-year mortality.

Results

Among 2359 women included in the analysis (median age, 71 [IQR, 64-78] years), the median diagnostic interval was 33 (IQR, 10-149) days. Compared with all other quartiles, patients in the second-shortest quartile of the diagnostic interval were more likely to be diagnosed at localized (83 of 586 [14.2%] vs 180 of 1773 [10.2%]) or regional (134 of 586 [22.9%] vs 330 of 1773 [18.6%]) stages ( P = .001) and had a median survival exceeding 5 years (lower 95% CI bound, 4.1 years), compared with median survivals of 2.5 years (95% CI, 2.0-3.1 years) in the shortest quartile and 2.9 years (95% CI, 2.5-3.8 years) in the longest quartile. When modeled using restricted cubic splines, the adjusted association between time to diagnosis and mortality was U-shaped; compared with a reference interval of 80 days, intervals of 10 and 360 days were associated with higher mortality (hazard ratios, 1.29 [95% CI, 1.09-1.53] and 1.13 [95% CI, 0.88-1.46], respectively). Conclusions and Relevance In this cohort study of patients with OC, very short diagnostic intervals were associated with poorer survival, consistent with residual confounding by the wait time paradox, while longer diagnostic intervals were also associated with worse outcomes. Conventional linear approaches may obscure this important confounding by severity in the association between diagnostic timing and survival, contributing to null findings in prior studies and potentially discouraging efforts to improve diagnosis of this difficult-to-detect disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsDelayed DiagnosisEarly Detection of CancerHumansFemaleNorth CarolinaAgedCohort StudiesUnited StatesRegistriesMiddle AgedTime FactorsTreatment Delay

Autor:innen und Institutionen

  • Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill.
  • Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill.
  • Division of Gynecologic Oncology, University of North Carolina at Chapel Hill, Chapel Hill.
  • Epidemiology of Cancer Healthcare and Outcomes, Department of Behavioural Science and Health, Institute of Epidemiology and Health Care, University College London, London, United Kingdom.

Zitieren

APA

Soppe, S. E., Kuo, T. M., Bae-Jump, V. L., Albright, B. B., Lyratzopoulos, G., Baggett, C. D., & Thompson, C. A. (2026). Diagnostic Timing and Ovarian Cancer Survival. JAMA Network Open, 9(3), e262434. https://doi.org/10.1001/jamanetworkopen.2026.2434

Vancouver

Soppe SE, Kuo TM, Bae-Jump VL, Albright BB, Lyratzopoulos G, Baggett CD, et al. Diagnostic Timing and Ovarian Cancer Survival. JAMA Network Open. 2026;9(3):e262434. doi:10.1001/jamanetworkopen.2026.2434

BibTeX
@article{Soppe2026,
  author = {Soppe, Sarah E and Kuo, Tzy-Mey and Bae-Jump, Victoria L and Albright, Benjamin B and Lyratzopoulos, Georgios and Baggett, Chris D and Thompson, Caroline A},
  title = {Diagnostic Timing and Ovarian Cancer Survival},
  journal = {JAMA Network Open},
  year = {2026},
  volume = {9},
  number = {3},
  pages = {e262434},
  doi = {10.1001/jamanetworkopen.2026.2434}
}
Kostenlos starten →